$HRTX, Stock Focus: Heron Therapeutics, Inc. (N
Post# of 22756
(Total Views: 80)
Posted On: 02/26/2017 9:43:00 PM
$HRTX,
Stock Focus: Heron Therapeutics, Inc. (NASDAQ:HRTX) Price Target Update
During the most recent trading session, shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) changed +1.09%. Street analysts that track the company are anticipating the stock to go to $31.11 within the next year. Target price projections may vary greatly depending on the specific analyst providing data. This consensus target is compiled using analysts polled by Thomson Reuters.
After a look at recent stock performance, Heron Therapeutics, Inc. (NASDAQ:HRTX) shares have traded $0.51 off of the 50-day moving average of $13.39 and $-2.16 off of the 200-day moving average of $16.06. Shares have been recorded at -45.40% separated from the 52-week high of 25.46 and +13.84% away from the 52-week low of 12.21. Tracking the stock price in relation to moving averages as well as highs and lows for the year might assist with evaluating future stock performance.
Street analysts have the ability to employ multiple metrics to help calculate target price estimates. A common metric is a company’s P/E Ratio. This calculation is derived by dividing the current share price by the projected earnings per share. Heron Therapeutics, Inc. presently has a P/E Ratio of N/A. Investors may also monitor a company’s PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. A PEG Ratio under one may indicate that the company is undervalued. If a company has a PEG Ratio above one, it may represent that the company is overvalued. A PEG Ratio near one might be seen as fair value. Heron Therapeutics, Inc. (NASDAQ:HRTX) has a current PEG Ratio of 0.18.
Stock Focus: Heron Therapeutics, Inc. (NASDAQ:HRTX) Price Target Update
During the most recent trading session, shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) changed +1.09%. Street analysts that track the company are anticipating the stock to go to $31.11 within the next year. Target price projections may vary greatly depending on the specific analyst providing data. This consensus target is compiled using analysts polled by Thomson Reuters.
After a look at recent stock performance, Heron Therapeutics, Inc. (NASDAQ:HRTX) shares have traded $0.51 off of the 50-day moving average of $13.39 and $-2.16 off of the 200-day moving average of $16.06. Shares have been recorded at -45.40% separated from the 52-week high of 25.46 and +13.84% away from the 52-week low of 12.21. Tracking the stock price in relation to moving averages as well as highs and lows for the year might assist with evaluating future stock performance.
Street analysts have the ability to employ multiple metrics to help calculate target price estimates. A common metric is a company’s P/E Ratio. This calculation is derived by dividing the current share price by the projected earnings per share. Heron Therapeutics, Inc. presently has a P/E Ratio of N/A. Investors may also monitor a company’s PEG or price to earnings growth ratio. The PEG ratio represents the ratio of the price to earnings to the anticipated future growth rate of the company. A PEG Ratio under one may indicate that the company is undervalued. If a company has a PEG Ratio above one, it may represent that the company is overvalued. A PEG Ratio near one might be seen as fair value. Heron Therapeutics, Inc. (NASDAQ:HRTX) has a current PEG Ratio of 0.18.
(0)
(0)
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
Scroll down for more posts ▼